المؤلفون: Gray, Robert D., Downey, Damien, Taggart, Clifford C.

المصدر: Gray , R D , Downey , D & Taggart , C C 2017 , ' Biomarkers to monitor exacerbations in cystic fibrosis ' , Expert Review of Respiratory Medicine , vol. 11 , no. 4 , pp. 255-257 . https://doi.org/10.1080/17476348.2017.1307739Test

مصطلحات موضوعية: biomarker, cystic fibrosis, Exacerbation, inflammation, /dk/atira/pure/subjectarea/asjc/2700/2723, Immunology and Allergy, /dk/atira/pure/subjectarea/asjc/2700/2740, Pulmonary and Respiratory Medicine, /dk/atira/pure/subjectarea/asjc/2700/2739, Public Health, Environmental and Occupational Health, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, SDG 3 - Good Health and Well-being

الإتاحة: https://doi.org/10.1080/17476348.2017.1307739Test
https://pure.qub.ac.uk/en/publications/3059e5ed-3578-4a2b-ad9c-e666f61ce92fTest
http://www.scopus.com/inward/record.url?scp=85016304603&partnerID=8YFLogxKTest

المؤلفون: Sivagurunathan Sutharsan, Edward F McKone, Damian G Downey, Jamie Duckers, Gordon MacGregor, Elizabeth Tullis, Eva Van Braeckel, Claire E Wainwright, Danie Watson, Neil Ahluwalia, Bote G Bruinsma, Christopher Harris, Anna P Lam, Yiyue Lou, Samuel M Moskowitz, Simon Tian, Jason Yuan, David Waltz, Marcus A Mall, Paul Aurora, Stijn Verhulst, Michael Lorenz, Jobst Roehmel, Wolfgang Gleiber, Susanne Naehrig, Florian Stehling, Silke van Koningsbruggen-Rietschel, Rainald Fischer, Damian Downey, Charles Haworth, Julian Legg, Peter Barry, Rebecca Thursfield, Simon James Doe, Tom Hilliard, Edward F Nash, Nicholas John Withers, Daniel Peckham, Helen Louise Barr, Timothy Lee, Robert Gray, Francois Vermeulen, Eef Vanderhelst, Philip J Robinson, Daniel J Smith, Siobhain A Mulrennan, Barry S Clements, Peter Wark

المساهمون: Aurora, Paul (Beitragende*r), Verhulst, Stijn (Beitragende*r), Lorenz, Michael (Beitragende*r), Roehmel, Jobst (Beitragende*r), Gleiber, Wolfgang (Beitragende*r), Naehrig, Susanne (Beitragende*r), Stehling, Florian (Beitragende*r), van Koningsbruggen-Rietschel, Silke (Beitragende*r), Fischer, Rainald (Beitragende*r), Haworth, Charles (Beitragende*r), Legg, Julian (Beitragende*r), Barry, Peter (Beitragende*r), Thursfield, Rebecca (Beitragende*r), Doe, Simon James (Beitragende*r), Hilliard, Tom (Beitragende*r), Nash, Edward F (Beitragende*r), Withers, Nicholas John (Beitragende*r), Peckham, Daniel (Beitragende*r), Barr, Helen Louise (Beitragende*r), Lee, Timothy (Beitragende*r), Gray, Robert (Beitragende*r), Vermeulen, Francois (Beitragende*r), Vanderhelst, Eef (Beitragende*r), Robinson, Philip J (Beitragende*r), Smith, Daniel J (Beitragende*r), Mulrennan, Siobhain A (Beitragende*r), Clements, Barry S (Beitragende*r), Wark, Peter (Beitragende*r), Physiotherapy, Human Physiology and Anatomy, Clinical sciences, Pneumology

المصدر: VX18-445-109 study group 2021, ' Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial ', The Lancet. Respiratory medicine . https://doi.org/10.1016/S2213-2600Test(21)00454-9

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Indoles, Pyrrolidines, F508del-CFTR allele, Cystic Fibrosis, aged 12 years or older, Pyridines, Medizin, Cystic Fibrosis Transmembrane Conductance Regulator, Quinolones, Aminophenols, Double-Blind Method, Mutation, Quality of Life, Humans, Pyrazoles, cystic fibrosis transmembrane conductance regulator (CFTR), Benzodioxoles, Child, Chloride Channel Agonists

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75c34a7aa3d2d4d1a01b05a402f021fcTest
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85124502293Test